Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that it enclosed the schedule of Earnings Call to be held on August 12, 2024, at 8:30 am (IST) on Unaudited Financial Results of the Company for the first quarter ended June 30, 2024.
The above information is a part of company’s filings submitted to BSE.